本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

25.86
+0.29001.13%
成交量:33.81万
成交额:860.60万
市值:41.31亿
市盈率:-62.87
高:25.86
开:25.47
低:24.66
收:25.57
52周最高:30.74
52周最低:12.00
股本:1.60亿
流通股本:1.25亿
量比:0.47
换手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):-0.4113
每股收益(LYR):-0.3922
净资产收益率:-38.76%
总资产收益率:-4.12%
市净率:28.91
市盈率(LYR):-65.94

数据加载中...

2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report